Eagle Pharmaceuticals (EGRX) Form 4 EAGLE PHARMACEUTICALS / ALAIN SCHREIBER ownership change

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:	3235-0287
Estimated average burden
hours per response:	0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

ProQuest Investments IV, L.P.

(Last) (First) (Middle)

2430 VANDERBILT BEACH ROAD, #108 - 190

(Street)

NAPLES FL 34109

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
EAGLE PHARMACEUTICALS, INC. [ EGRX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

Director	X	10% Owner
Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
03/30/2017

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

	Form filed by One Reporting Person
X	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock $0.001 par value	03/30/2017		S		6,223	D	$83(3)	3,669,196	I	By ProQuest Investments IV, L.P.(1)
Common Stock $0.001 par value	03/31/2017		S		23,689	D	$83.02(4)	3,645,507	I	By ProQuest Investments IV, L.P.(1)
Common Stock $0.001 par value	04/03/2017		S		61,420	D	$83.13(5)	3,584,087	I	By ProQuest Investments IV, L.P.(1)
Common Stock $0.001 par value								6,777	I	By ProQuest Financial LLC(2)
Common Stock $0.001 par value								23,274	I	By Jay Moorin through IRA

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

1. Name and Address of Reporting Person^*

ProQuest Investments IV, L.P.

(Last) (First) (Middle)

2430 VANDERBILT BEACH ROAD, #108 - 190

(Street)

NAPLES FL 34109

(City) (State) (Zip)

1. Name and Address of Reporting Person^*

ProQuest Financial LLC

(Last) (First) (Middle)

2430 VANDERBILT BEACH ROAD, #108-190

(Street)

NAPLES FL 34109

(City) (State) (Zip)

1. Name and Address of Reporting Person^*

ProQuest Associates IV LLC

(Last) (First) (Middle)

2430 VANDERBILT BEACH ROAD, #108 - 190

(Street)

NAPLES FL 34109

(City) (State) (Zip)

1. Name and Address of Reporting Person^*

Moorin Jay

(Last) (First) (Middle)

C/O PROQUEST INVESTMENTS

2430 VANDERBILT BEACH ROAD, #108 - 190

(Street)

NAPLES FL 34109

(City) (State) (Zip)

1. Name and Address of Reporting Person^*

SCHREIBER ALAIN

(Last) (First) (Middle)

C/O PROQUEST INVESTMENTS

2430 VANDERBILT BEACH ROAD, #108 - 190

(Street)

NAPLES FL 34109

(City) (State) (Zip)

Explanation of Responses:

1. The shares are held by ProQuest Investments IV, L.P. ("Investments IV"), which ProQuest Financial LLC ("ProQuest Financial") manages. Jay Moorin and Alain Schreiber are managing members of ProQuest Financial and each of them disclaims beneficial ownership of such securities except to the extent of his pecuniary interest in such securities.

2. Jay Moorin and Alain Schreiber are managing members of ProQuest Financial and each of them disclaims beneficial ownership of such securities except to the extent of his pecuniary interest in such securities.

3. Constitutes the weighted average purchase price for multiple transactions reported on this line having prices per share ranging from $83.00 to $83.03. The Reporting Persons will provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding each separate transaction.

4. Constitutes the weighted average purchase price for multiple transactions reported on this line having prices per share ranging from $83.00 to $83.42. The Reporting Persons will provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding each separate transaction.

5. Constitutes the weighted average purchase price for multiple transactions reported on this line having prices per share ranging from $83.00 to $83.51. The Reporting Persons will provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding each separate transaction.

Remarks:

	/s/ Pasquale DeAngelis	04/03/2017
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.